The main purpose of this legislation is to modify the rules surrounding fee waivers for small businesses that register their establishments under the Federal Food, Drug, and Cosmetic Act. The goal is to ease the financial burden on small businesses in the medical device industry by allowing them to waive certain fees associated with annual registration. Key provisions of the legislation include a revised definition of a small business, which is now defined as an entity with fewer than 20 full-time equivalent employees.